Sarah Teichmann is a systems and genome biologist who heads the Cellular Genetics programme at the Wellcome Sanger Institute and is Director of Research at the Cavendish Lab/Dept Physics at the University of Cambridge. Born in Germany to an American mother and German father, she studied biochemistry at Cambridge before completing her PhD at the MRC Laboratory of Molecular Biology.
Sarah’s lab at the Sanger develops and applies cell atlas technologies to decipher human tissue architecture. She is particularly interested in how cellular diversity is generated in the immune system and through development. She has charted the first at-scale maps of various organs and organ systems, and applied her single cell toolkit to diseases from COVID-19 to cancer.
Sarah is co-founder and co-leader of the international Human Cell Atlas consortium together with Aviv Regev (initially at the Broad Institute, now Genentech). This project aims to create reference maps for cells across all human tissues, and has grown to include over two thousand members across the world.
Sarah’s work has been recognised by numerous awards, including the EMBO Gold Medal, Genetics Society Mary Lyons Award and Biochemical Society GlaxoSmithKline Award among others. She is an EMBO Member, ISCB Fellow, and Fellow of the Academy of Medical Sciences and Royal Society.
Contact: st9@sanger.ac.uk
